Correlations of serum hepatitis C virus RNA and alanine transaminase with liver histopathological changes in patients with chronic hepatitis C

Laboratory Medicine

Volumn 40, Issue 3, 2009, Pages 167-169

  Liu, Pei ^a   Li, Ying ^a   Sun, Cui Ming ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LIVER NECROSIS; MAJOR CLINICAL STUDY; MALE; VIRUS LOAD;

HEPATITIS C VIRUS;

EID: 77956961392     PISSN: 00075027     EISSN: 19437730     Source Type: Journal    
DOI: 10.1309/LM5XQBWG0QMLNNPC     Document Type: Article

References (25)

1. Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989;244:359-362.
2. Lau GKK, Zhuang H. Top hepatology issue in China. J Gastroent Hepatol. 2003;17:A9.
3. Alberti A, Benvegnu L. Management of hepatitis C. J Hepatol. 2003;38:S104-S118.
4. EL-Serag HB. Hepatocellular carcinoma: Recent trends in the United States. Gastroenterology. 2004;127:S27-S34. (Pubitemid 39423367)
5. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005;5:558-567.
6. Adinolfi LE, Utili R, Andreana A, Tripodi MF, et al. Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C. Dig Dis Sci. 2001;46:1677-1683. (Pubitemid 32727098)
7. Zechini B, Pasquazzi C, Aceti A. Correlation of serum aminotransferases with HCV RNA levels and histological findings in patients with chronic hepatitis C: The role of serum aspartate transaminase in the evaluation of disease progression. Eur J Gastroenterol Hepatol. 2004;16:891-896.
8. Puoti C, Magrini A, Stati T, et al. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels. Hepatology. 1997;26:1393-1398.
9. Anand BS, Velez M. Assessment of correlation between serum titers of hepatitis C virus and severity of liver disease. World J Gastroenterol. 2004;10:2409-2411. (Pubitemid 39157769)
10. Bacon BR. Treatment of patients with hepatitis C and normal serum aminotransferase levels. Hepatology. 2002;36:S179-S184.
11. Knodell R, Ishak K, Black W, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981;1:431-435. (Pubitemid 12218164)
12. Scheuer PJ. Classification of chronic viral hepatitis: A need for reassessment. J Hepatol. 1991;13:372-374.
13. EL-Serag HB. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology. 2002;36:S74-S83.
14. Marcellin P, Asselah T, Boyer N. Fibrosis and disease progression in hepatitis C. Hepatology. 2002;36:S47-S56.
15. Orellana NI, Poniachik TJ, Smok SG, et al. Factors associated with the severity of liver damage in chronic hepatitis C. Rev Med Chil. 2005;133:1311-1316.
16. Ramos Gomez M. Natural history of chronic hepatitis C. Rev Gastroenterol Mex. 2002;67:S17-S20.
17. Sangiovanni A, Morales R, Spinzi GC, et al. Interferon alfa treatment of HCV carriers with persistently normal transaminase levels: A pilot randomized controlled study. Hepatology. 1998;27:853-856. (Pubitemid 28103565)
18. Kuzushita N, Hayashi N, Katayama K, et al. Increased frequency of HLA DR13 in hepatitis C virus carriers with persistent normal ALT level. J Med Virol. 1996;48:1-7.
19. Calabrese F, Pontisso P, Pettenazzo E, et al. Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels. Hepatology. 2000;31:1153-1159.
20. Kao JH, Lai MY, Chen PJ, et al. Clinical significance of serum hepatitis C virus titer in patients with chronic type C hepatitis. Am J Gastroenterol. 1996;91:506-510. (Pubitemid 26083554)
21. Zeuzem S, Franke A, Lee JH, et al. Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology. Hepatology. 1996;24:1003-1009.
22. Kato NK, Hosoda K, Ito Y, et al. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: Increase of the virus in advanced liver disease. Hepatology. 1993;18:16-20.
23. Fanning L, Kenny E, Sheehan M, et al. Viral load and clinicopathological features of chronic hepatitis C(1b) in a homogenous population. Hepatology. 1999;29:904-907. (Pubitemid 29109608)
24. Zeuzem S, Lee JH, Franke A, et al. Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa. Hepatology. 1998;27:1149-1156.
25. Davis GL. Monitoring of viral levels during therapy of hepatitis C. Hepatology. 2002;36:S145-S151. (Pubitemid 35253475)